All Stories

  1. Seventy-Five Years of Research on Protein Binding

    Article • Antimicrobial Agents and Chemotherapy, November 2017, ASM Journals

    Professor Axel Albert Dalhoff

  2. Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections

    Article • Antimicrobial Agents and Chemotherapy, February 2017, ASM Journals

    Professor Axel Albert Dalhoff

  3. Pharmacokinetics and Pharmacodynamics of Aerosolized Antibacterial Agents in Chronically Infected Cystic Fibrosis Patients

    Article • Clinical Microbiology Reviews, October 2014, ASM Journals

    Professor Axel Albert Dalhoff

  4. In vitro activity of MCB3681 against Clostridium difficile strains

    Article • Anaerobe, August 2014, Elsevier

    Professor Axel Albert Dalhoff

  5. Ecological impact of MCB3837 on the normal human microbiota

    Article • International Journal of Antimicrobial Agents, August 2014, Elsevier

    Professor Axel Albert Dalhoff

  6. Alternative Strategies for Proof-of-Principle Studies of Antibacterial Agents

    Article • Antimicrobial Agents and Chemotherapy, May 2014, ASM Journals

    Professor Axel Albert Dalhoff

  7. Evaluation of the effect of serum proteins on the antibacterial activity and pharmacodynamics of ceftaroline against Staphylococcus aureus

    Article • International Journal of Antimicrobial Agents, September 2013, Elsevier

    Professor Axel Albert Dalhoff

  8. Aerosolised levofloxacin in cystic fibrosis

    Article • Expert Opinion on Orphan Drugs, July 2013, Informa Healthcare

    Professor Axel Albert Dalhoff

  9. Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use

    Article • Interdisciplinary Perspectives on Infectious Diseases, January 2012, Hindawi Publishing Corporation

    Professor Axel Albert Dalhoff

  10. Urinary Pharmacokinetics and Bactericidal Activity of Finafloxacin (200 and 800 mg) in Healthy Volunteers Receiving a Single Oral Dose

    Article • Chemotherapy, January 2011, Karger Publishers

    Professor Axel Albert Dalhoff

  11. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones

    Article • International Journal of Antimicrobial Agents, September 2010, Elsevier

    Professor Axel Albert Dalhoff

  12. Antibacterial Activity Of Ciprofloxacin (CIP) Against Immobilised Pseudomonas Aeruginosa (PA)

    Article • May 2010, American Thoracic Society

    Professor Axel Albert Dalhoff

  13. Permeation Of Ciprofloxacin Through Pseudomonas Aeruginosa (PA) Alginate

    Article • May 2010, American Thoracic Society

    Professor Axel Albert Dalhoff

  14. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study)

    Article • International Journal of Antimicrobial Agents, January 2009, Elsevier

    Professor Axel Albert Dalhoff

  15. Redefining penems

    Article • Biochemical Pharmacology, March 2006, Elsevier

    Professor Axel Albert Dalhoff

  16. Pharmacokinetics of ciprofloxacin XR (1000mg) versus levofloxacin (500mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose

    Article • International Journal of Antimicrobial Agents, January 2006, Elsevier

    Professor Axel Albert Dalhoff

  17. Immunomodulatory effects of quinolones

    Article • The Lancet Infectious Diseases, June 2003, Elsevier

    Professor Axel Albert Dalhoff

  18. The Art of Fusion: From Penams and Cephems to Penems

    Article • Chemotherapy, January 2003, Karger Publishers

    Professor Axel Albert Dalhoff

  19. In vitro activities of quinolones

    Article • Expert Opinion on Investigational Drugs, February 1999, Informa Healthcare

    Professor Axel Albert Dalhoff

  20. Band 2: Enzymes and other Molecular Targets. Bandherausgeber:P. G. Sammes. XVII, 887 S. — ISBN 0-08-037058-6

    Article • Angewandte Chemie, March 1991, Wiley

    Professor Axel Albert Dalhoff

  21. Effect of β-Lactam Antibiotics on the Bactericidal Activity of Polymorphonuclear Leukocytes against Escherichia Coli

    Article • January 1987, Springer Science + Business Media

    Professor Axel Albert Dalhoff

  22. Synergy between acylureidopenicillins and immunoglobulin G in experimental animals

    Article • The American Journal of Medicine, March 1984, Elsevier

    Professor Axel Albert Dalhoff

  23. Influence of β-lactam antibiotics in vitro on mixed cultures ofEscherichia coli andStreptococcus faecalis

    Article • Current Microbiology, September 1982, Springer Science + Business Media

    Professor Axel Albert Dalhoff

  24. Therapy of infections caused by mixed cultures ofEscherichia coli andStreptococcus faecalis

    Article • Current Microbiology, September 1982, Springer Science + Business Media

    Professor Axel Albert Dalhoff

  25. The “glucose effect” on growth inhibition of Escherichia coli by streptomycin, trimethoprim and sulfamethoxazole, respectively

    Article • FEMS Microbiology Letters, August 1979, Oxford University Press (OUP)

    Professor Axel Albert Dalhoff

  26. Anti-inflammatory properties of antibiotics other than macrolides

    Article • Springer Science + Business Media

    Professor Axel Albert Dalhoff